China Approval Watch: September Dominated By Generics And Vaccines
Executive Summary
Twenty-three chemical drugs, three biologics and one traditional Chinese medicine are among the latest approvals granted by the China FDA, which is continuing on a hiring spree to increase its number of reviewers.